IAVI

Mission

IAVI was founded in 1996 to address the dire need for an HIV/AIDS vaccine to end the AIDS pandemic. Since then, we have harnessed our expertise to develop an expanded portfolio of cutting-edge innovations addressing diseases of high unmet need, including those with pandemic potential that lack commercial incentive. Our lean but agile team catalyzes promising scientific innovation to tackle the most pressing global health challenges and pioneer novel partnership strategies to translate scientific discovery into real-world impact.

Vision

A world where all people have equitable access to innovative health products.

Goals

1.Drive progress in HIV vaccine development through the innovative Germline Targeting (GT) strategy.
2.Facilitate TB vaccine development to prevent disease - Catalyze and support leading TB programs and generate promising next-generation candidates.
3.Advance a flexible platform for emerging infectious diseases (EID)

New York NY | EIN: 13-3870223

Profile managed by nonprofit | Is this your nonprofit?

501(c)(3) organization

125 Broad Street, 9th Floor,
New York NY 10004

https://www.iavi.org

212-847-1111

IAVI

Mission

Vision

A world where all people have equitable access to innovative health products.

Goals

1.Drive progress in HIV vaccine development through the innovative Germline Targeting (GT) strategy.
2.Facilitate TB vaccine development to prevent disease - Catalyze and support leading TB programs and generate promising next-generation candidates.
3.Advance a flexible platform for emerging infectious diseases (EID)

New York NY | EIN: 13-3870223

Profile managed by nonprofit | Is this your nonprofit?

501(c)(3) organization

125 Broad Street, 9th Floor,
New York NY 10004

https://www.iavi.org

212-847-1111

Beacon Report

Great
Good
Needs Improvement
Poor
Not Scored
Additional Information

Program Expense Ratio:87.67% of total expenses

SCORE100%

Liabilities to Assets Ratio:60.42% of total assets

SCORE48%

Working Capital:0.38 years of reserves

SCORE71%

Fundraising Efficiency:$0.00 to raise a dollar

SCORE100%

Evaluation area metrics
Score	Metric
100%	Program Expense Ratio:87.67% of total expenses
48%	Liabilities to Assets Ratio:60.42% of total assets
71%	Working Capital:0.38 years of reserves
100%	Fundraising Efficiency:$0.00 to raise a dollar

Science behind the numbers

Error attempting donation

You're too fast!

Mission

Mission

Beacon Report